No Data
Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript
Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript
Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript
Standard BioTools | 10-Q: Quarterly report
Standard BioTools Reaffirms Guidance
Outlook for 2024For fiscal year 2024, the Company reaffirmed full year revenue guidance, which is expected to be in the range of $200 million to $205 million.
Standard BioTools: Strategic Insights and Regulatory Updates
Standard BioTools Q1 2024 GAAP EPS $(0.27) Misses $(0.12) Estimate, Sales $45.540M Miss $46.006M Estimate
Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.12) by 125 percent. This is a 28.57 percent decrease over losses of $(0